| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.71B | 63.35B | 64.55B | 58.42B | 55.14B | 50.15B |
| Gross Profit | 13.81B | 13.53B | 15.51B | 14.12B | 14.63B | 12.38B |
| EBITDA | 6.46B | 6.74B | 8.63B | 7.54B | 8.51B | 7.58B |
| Net Income | 1.20B | 1.79B | 4.01B | 3.38B | 4.22B | 3.96B |
Balance Sheet | ||||||
| Total Assets | 94.62B | 105.83B | 121.99B | 116.02B | 109.67B | 106.50B |
| Cash, Cash Equivalents and Short-Term Investments | 25.22B | 35.68B | 37.27B | 38.84B | 38.04B | 38.56B |
| Total Debt | 18.85B | 614.00M | 291.00M | 277.00M | 404.00M | 1.67B |
| Total Liabilities | 29.14B | 14.04B | 14.04B | 11.77B | 11.34B | 12.76B |
| Stockholders Equity | 64.22B | 90.45B | 106.30B | 102.67B | 96.89B | 92.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.57B | 1.02B | 1.82B | 3.89B | 4.81B |
| Operating Cash Flow | 0.00 | 8.12B | 8.37B | 6.07B | 6.44B | 7.34B |
| Investing Cash Flow | 0.00 | 3.34B | -8.57B | -5.00B | -3.86B | -2.58B |
| Financing Cash Flow | 0.00 | -6.47B | -4.70B | -2.44B | -4.69B | 300.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥114.66B | 10.43 | ― | 3.01% | 7.72% | 12.07% | |
79 Outperform | ¥441.92B | 11.25 | ― | 1.60% | -5.16% | 200.96% | |
77 Outperform | ¥122.96B | 7.27 | ― | 3.30% | 0.29% | 9.87% | |
75 Outperform | ¥504.17B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
73 Outperform | ¥134.14B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥41.58B | 50.47 | ― | 5.35% | -6.20% | -64.65% |